Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
|Articles|February 4, 2021
SMA MicroPortable ICS Air Sampler
Author(s)Veltek Associates, Inc.
The new SMA MicroPortable ICS has been designed for superior precision and control of portable air sampling with an intuitive touchscreen, automatic configurations, three flow rates, and remote accessibility.
VAI’s new SMA MicroPortable ICS Air Sampler has been designed to provide superior precision and control of portable air sampling within the cleanroom and in critical environments. Compatible with traditional SMA Atriums and D50 SMA Atriums, operators are provided with the ability to automate flow control and automatically configure sample intervals with ease. For cleanroom compatibility, the unit has been designed with a 316L Stainless Steel housing that is lightweight, with an integrated intuitive touchscreen for use with gloved hands. In addition, the unit is flexible with three flow rates available, 1, 2, and 5 CFM.
The SMA MicroPortable ICS is a networked device that may be remotely accessed by operators and administrators. The device can export event history to a removable USB flash drive that includes sampling and calibration events. Furthermore, the unit is equipped with a strict regulation of air flow and will alarm the operator if the air flow deviates beyond the acceptable range. The system also monitors and indicates a variety of operational parameters including the sample’s volume and elapsed time. The unit is battery powered with eight hours of life on a full charge.
Veltek Associates, Inc.
Related to this article
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.